This report lists the top PD-1 And PD-L1 Inhibitors companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the PD-1 And PD-L1 Inhibitors i
PD-1およびPD-L1阻害剤市場は、今後5年間で17.96%のCAGRで成長する。Bristol-Myers Squibb Company、Merck Co.、F. Hoffmann-La Roche AG、Pfizer Inc.、GSK plcがPD-1およびPD-L1阻害剤市場で事業を展開している主要企業です。
1 Zhou CC, Wang J, Bu H, et al. Chinese experts consensus on immune checkpoint inhibitors for non-small cell lung cancer (2019 version). Zhongguo Fei Ai Za Zhi, 2020, 23(2): 65-76. [周彩存, 王洁, 步宏, 等. 中国非小细胞肺癌免疫检查点抑制剂治疗专家共识(2019年版). 中国肺癌杂志, ...